13F

Stock

Galmed Pharmaceuticals Ltd.

GLMD · held by 16 managers

Reported value

$71.2K

Holders

16

+0 new · −1 exited

Holders’ est. mark

−$33.8K

Price effect on 16 books still in the name

Largest holder

$39.3K

TWO SIGMA INVESTMENTS, LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
TWO SIGMA INVESTMENTS, LP80.2K$39.3K−$20.9KCut−$44.9K
XTX Topco Ltd22.4K$10.8K−$2.95KAdded$2.53K
JANE STREET GROUP, LLC16.4K$8.06K−$3.16KCut−$1.05K
TWO SIGMA SECURITIES, LLC12K$5.87K−$3.12KCut−$4.34K
Citadel11.4K$5.5K−$3.04KCut−$23.2K
UBS Group AG2.55K$1.25K−$471Cut−$112
BNP PARIBAS FINANCIAL MARKETS600$294−$156Cut−$381
MORGAN STANLEY157$77−$41Cut−$147
WELLS FARGO & COMPANY/MN43$21−$3Added$14
SBI Securities Co., Ltd.16$8−$4Cut−$4
Federation des caisses Desjardins du Quebec14$7−$4Cut−$4
OSAIC HOLDINGS, INC.5$2−$1Cut−$1
Allworth Financial LP2$1−$1Cut−$1
ELEVATION WEALTH PARTNERS, LLC1$1$0Held
TSFG, LLC17$0$0Held
Dogwood Wealth Management LLC1$0−$1Cut−$1

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.